Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy
Top Cited Papers
- 12 November 2009
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 124 (6), 1319-1325.e3
- https://doi.org/10.1016/j.jaci.2009.09.022
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Primary resistance to imatinib in Fip1-like 1–platelet-derived growth factor receptor α—positive eosinophilic leukemiaJournal of Allergy and Clinical Immunology, 2008
- Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levelsJournal of Allergy and Clinical Immunology, 2008
- Approaches to the treatment of hypereosinophilic syndromes: A workshop summary reportJournal of Allergy and Clinical Immunology, 2006
- Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogeneticsLeukemia, 2005
- FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophiliaBlood, 2004
- Safety and efficacy of the monoclonal anti–interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndromeBlood, 2004
- Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsivenessBlood, 2003
- Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic EosinophiliaNew England Journal of Medicine, 1999
- Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levelsArchives of Internal Medicine, 1978
- THE HYPEREOSINOPHILIC SYNDROMEMedicine, 1975